loading
Schlusskurs vom Vortag:
$6.48
Offen:
$6.48
24-Stunden-Volumen:
49,790
Relative Volume:
0.04
Marktkapitalisierung:
$707.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-167.48M
KGV:
-3.3106
EPS:
-1.95
Netto-Cashflow:
$-197.47M
1W Leistung:
+2.22%
1M Leistung:
+2.54%
6M Leistung:
-49.81%
1J Leistung:
-53.29%
1-Tages-Spanne:
Value
$6.37
$6.48
1-Wochen-Bereich:
Value
$6.20
$6.595
52-Wochen-Spanne:
Value
$6.08
$16.76

Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile

Name
Firmenname
Day One Biopharmaceuticals Inc
Name
Telefon
650 484-0899
Name
Adresse
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Name
Mitarbeiter
181
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
DAWN's Discussions on Twitter

Vergleichen Sie DAWN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
DAWN
Day One Biopharmaceuticals Inc
6.46 707.51M 0 -167.48M -197.47M -1.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.19 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
528.23 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
317.08 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
563.28 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.24 28.51B 3.81B -644.79M -669.77M -6.24

Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-10-09 Bestätigt Needham Buy
2024-08-01 Hochstufung BofA Securities Underperform → Buy
2024-04-24 Bestätigt Needham Buy
2023-04-25 Herabstufung BofA Securities Buy → Underperform
2023-02-08 Eingeleitet CapitalOne Overweight
2023-02-03 Eingeleitet Oppenheimer Perform
2022-12-15 Eingeleitet H.C. Wainwright Buy
2022-12-14 Eingeleitet Needham Buy
2022-12-05 Eingeleitet Goldman Buy
2022-12-01 Eingeleitet BofA Securities Buy
Alle ansehen

Day One Biopharmaceuticals Inc Aktie (DAWN) Neueste Nachrichten

pulisher
Jun 19, 2025

Day 8 of Loss Streak for Day One Biopharmaceuticals Stock with -11% Return (vs. -49% YTD) [6/18/2025] - Trefis

Jun 19, 2025
pulisher
Jun 16, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of “Buy” by Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Takes Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Has $260,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Where are the Opportunities in (DAWN) - news.stocktradersdaily.com

Jun 13, 2025
pulisher
Jun 11, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Transcript : Day One Biopharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Day One Appoints Michael Vasconcelles As Head Of Research And Development - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Day One Biopharmaceuticals (DAWN) Welcomes New R&D Leader | DAWN Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development - GlobeNewswire

Jun 10, 2025
pulisher
Jun 10, 2025

Day One Taps ImmunoGen Executive to Lead R&D: 25-Year Oncology Expert Joins Cancer Drug Developer - Stock Titan

Jun 10, 2025
pulisher
Jun 08, 2025

H.C. Wainwright Maintains Buy Rating on Day One Biopharmaceuticals (DAWN), Keeps PT - MSN

Jun 08, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Decreases Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Squarepoint Ops LLC Acquires New Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

JonesTrading Maintains Buy Rating on Day One Biopharmaceuticals (DAWN) Following Ojemda’s FDA Approval - Insider Monkey

Jun 05, 2025
pulisher
Jun 04, 2025

Day One Biopharmaceuticals: Strong Ojemda Potential In Q2 And Solid Rationale For DAY-301 - Seeking Alpha

Jun 04, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Lowers Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Bought by Millennium Management LLC - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Increases Stock Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 1,894 Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 30, 2025
pulisher
May 29, 2025

Cetera Investment Advisers Has $400,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 29, 2025
pulisher
May 25, 2025

36,685 Shares in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Bought by BNP Paribas Financial Markets - Defense World

May 25, 2025
pulisher
May 22, 2025

D. E. Shaw & Co. Inc. Increases Stock Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 22, 2025
pulisher
May 22, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Rating of “Buy” from Brokerages - Defense World

May 22, 2025
pulisher
May 20, 2025

We Think Day One Biopharmaceuticals (NASDAQ:DAWN) Can Afford To Drive Business Growth - Yahoo Finance

May 20, 2025
pulisher
May 20, 2025

Northern Trust Corp Grows Holdings in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World

May 20, 2025
pulisher
May 19, 2025

Day one Biopharmaceuticals officer sells $24,574 in stock By Investing.com - Investing.com Nigeria

May 19, 2025
pulisher
May 19, 2025

Day one Biopharmaceuticals officer sells $24,574 in stock - Investing.com

May 19, 2025
pulisher
May 19, 2025

Day One Biopharmaceuticals Executives Sell Shares to Cover Tax Liabilities - TradingView

May 19, 2025
pulisher
May 15, 2025

Day one biopharmaceuticals highlights OJEMDA revenue growth and pipeline progress in Q1 2025 - MSN

May 15, 2025
pulisher
May 14, 2025

Day One Biopharmaceuticals Insider Lowered Holding By 20% During Last Year - simplywall.st

May 14, 2025
pulisher
May 14, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Stake Decreased by Voya Investment Management LLC - Defense World

May 14, 2025
pulisher
May 13, 2025

Transcript : Day One Biopharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Is Day One Biopharmaceuticals, Inc. (DAWN) the Best Low Priced Biotech Stock to Buy Now? - MSN

May 13, 2025
pulisher
May 12, 2025

10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 11, 2025

Trend Tracker for (DAWN) - news.stocktradersdaily.com

May 11, 2025
pulisher
May 11, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Down – Here’s What Happened - Defense World

May 11, 2025
pulisher
May 10, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Purchased by Dimensional Fund Advisors LP - Defense World

May 10, 2025
pulisher
May 10, 2025

Research Analysts Issue Forecasts for DAWN Q2 Earnings - Defense World

May 10, 2025
pulisher
May 10, 2025

Needham & Company LLC Cuts Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target to $27.00 - Defense World

May 10, 2025
pulisher
May 10, 2025

Research Analysts Set Expectations for DAWN Q2 Earnings - Defense World

May 10, 2025
pulisher
May 09, 2025

Is Day One Biopharmaceuticals, Inc. (DAWN) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Analysts Issue Forecasts for DAWN Q1 Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey

May 09, 2025
pulisher
May 08, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Shares Gap Up After Earnings Beat - Defense World

May 08, 2025
pulisher
May 08, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Mariner LLC - Defense World

May 08, 2025
pulisher
May 08, 2025

Day One Biopharmaceuticals (NASDAQ:DAWN) Reaches New 12-Month Low Following Analyst Downgrade - Defense World

May 08, 2025
pulisher
May 07, 2025

Day One Biopharma’s Earnings Call Highlights Growth - TipRanks

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals (DAWN) Target Price Adjusted to $26 | DAWN Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Needham Adjusts Price Target for DAWN to $27, Maintains Buy Rati - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025

Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Day One Biopharmaceuticals Inc-Aktie (DAWN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Dubow Adam
GENERAL COUNSEL
May 16 '25
Sale
6.26
4,552
28,486
47,136
York Charles N II
COO, CFO AND SECRETARY
May 16 '25
Sale
6.26
4,282
26,796
265,231
Bender Jeremy
CHIEF EXECUTIVE OFFICER
May 16 '25
Sale
6.26
13,964
87,385
145,737
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
Kapitalisierung:     |  Volumen (24h):